Document Detail

Early phase combined therapeutic management of acute ischaemic stroke.
MedLine Citation:
PMID:  15883687     Owner:  NLM     Status:  MEDLINE    
An adequate treatment of ischaemic stroke in the early phase (28-48 h) is the most important factor for a better outcome. Thrombolysis with rTPA (within 3 h) and oral ASA 300 mg/days are the first therapeutic misures. Continuous monitoring of cardiological and haemodinamic parameters allows early detection of cardiac disturbances. Treatment of hypertension, low haematic oxigenation, hyperglicaemia, seizures and hypertermia is basic to improve outcome. Pharmacological therapy is only one of the components of effective multidisciplinary integrated management of ischaemic stroke; we remind also the precocity of rehabilitation procedures and an accurate psychological assessment.
P Bassi; P Lattuada; S Tonietti
Related Documents :
570657 - Movement-activated central fast rhythms: an eeg finding in action myoclonus.
20839497 - Does exercise protect from cognitive decline by altering brain cytokine and apoptotic p...
12065337 - Cost-effectiveness of tuberculosis prophylaxis after release from short-term correction...
17036177 - Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine.
16002437 - Coordinated collagen and muscle protein synthesis in human patella tendon and quadricep...
8919257 - The human saphenous vein in pharmacology: effect of a new micronized flavonoidic fracti...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology     Volume:  26 Suppl 1     ISSN:  1590-1874     ISO Abbreviation:  Neurol. Sci.     Publication Date:  2005 May 
Date Detail:
Created Date:  2005-05-10     Completed Date:  2005-07-18     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  100959175     Medline TA:  Neurol Sci     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  S29-30     Citation Subset:  IM    
Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153 Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Brain Ischemia / drug therapy*
Emergency Treatment
Fibrinolytic Agents / therapeutic use*
Thrombolytic Therapy / methods*
Time Factors
Tissue Plasminogen Activator / therapeutic use*
Treatment Outcome
Reg. No./Substance:
0/Fibrinolytic Agents; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Specific therapies for ischaemic stroke: rTPA and others.
Next Document:  Antibodies associated with paraneoplastic neurological disorders.